83
Participants
Start Date
June 19, 2015
Primary Completion Date
March 17, 2021
Study Completion Date
March 17, 2021
BMS-986158
Specified dose on specified days
Nivolumab
Specified dose on specified days
Nucleus Network, Melbourne
Univ. Of Pa, Philadelphia
Centro Integral Oncologico Clara Campal, Madrid
Institute for Translational Oncology Research-ITOR, Greenville
Clinica Universidad de Navarra, Pamplona
Local Institution, Lyon
University Of Colorado, Aurora
City Of Hope National Medical Center, Duarte
Local Institution, Villejuif
Oregon Health & Science University, Portland
Dana Farber Cancer Institute., Boston
The Ottawa Hospital Cancer Centre, Ottawa
H. Univ. Vall dHebron, Barcelona
Lead Sponsor
Bristol-Myers Squibb
INDUSTRY